| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Virology, Department of Pathology, Cambridge University, Cambridge, U.K.
and2 Department of Pharmacology and Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27514, U.S.A.
Two TK+ acyclovir-resistant variants of herpes simplex virus (HSV) (S1 and Tr7) and one TK+ BVdU-resistant variant (B3) induce abnormal thymidine kinases with impaired ability to phosphorylate the drugs used in their isolation. These enzymes have been purified and their properties compared with those of the wild-type (wt) parent, SC16. The enzyme induced by S1 differed markedly from the other three in both its responses to salt and to pH. B3 TK recognized the enzyme's natural substrates, thymidine, deoxycytidine, dTMP and ATP as well as the wt enzyme. In contrast, Tr7 and S1 TKs failed to bind deoxycytidine and bind thymidine less well than wt. Tr7 and S1 TKs had affinities for dTMP similar to those of B3 and the wt enzymes. ATP binding to wt, Tr7 and B3 enzymes was similar but this substrate bound only weakly to S1 TK. Each mutant displayed a characteristically distinct pattern of affinities for a range of nucleoside analogue substrates, suggesting that they will show some cross-resistance to drugs which have a similar mechanism of action to acyclovir and BVdU.
Keywords: HSV, antiviral, thymidine kinase, resistant mutants
Received 23 August 1982;
accepted 12 October 1982.
This article has been cited by other articles:
|
|
 |
|
  G. Andrei, J. Balzarini, P. Fiten, E. De Clercq, G. Opdenakker, and R. Snoeck Characterization of Herpes Simplex Virus Type 1 Thymidine Kinase Mutants Selected under a Single Round of High-Dose Brivudin J. Virol., May 1, 2005; 79(9): 5863 - 5869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Frobert, T. Ooka, J. C. Cortay, B. Lina, D. Thouvenot, and F. Morfin Herpes Simplex Virus Thymidine Kinase Mutations Associated with Resistance to Acyclovir: a Site-Directed Mutagenesis Study Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1055 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Degrève, R. Esnouf, E. De Clercq, and J. Balzarini Mutation of Gln125 to Asn Selectively Abolishes the Thymidylate Kinase Activity of Herpes Simplex Virus Type 1 Thymidine Kinase Mol. Pharmacol., February 1, 2001; 59(2): 285 - 293. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. D. Pilger, R. Perozzo, F. Alber, C. Wurth, G. Folkers, and L. Scapozza Substrate Diversity of Herpes Simplex Virus Thymidine Kinase. IMPACT OF THE KINEMATICS OF THE ENZYME J. Biol. Chem., November 5, 1999; 274(45): 31967 - 31973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Perozzo, I. Jelesarov, H. R. Bosshard, G. Folkers, and L. Scapozza Compulsory Order of Substrate Binding to Herpes Simplex Virus Type 1 Thymidine Kinase. A CALORIMETRIC STUDY J. Biol. Chem., May 19, 2000; 275(21): 16139 - 16145. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
